NS-Pep: De novo Peptide Design with Non-Standard Amino Acids

2025-10-01T16:04:06Z

Peptide drugs incorporating non-standard amino acids (NSAAs) offer improved binding affinity and improved pharmacological properties. However, existing peptide design methods are limited to standard amino acids, leaving NSAA-aware design largely unexplored. We introduce NS-Pep, a unified framework for co-designing peptide sequences and structures with NSAAs. The main challenge is that NSAAs are extremely underrepresented-even the most frequent one, SEP, accounts for less than 0.4% of residues-resulting in a severe long-tailed distribution. To improve generalization to rare amino acids, we propose Residue Frequency-Guided Modification (RFGM), which mitigates over-penalization through frequency-aware logit calibration, supported by both theoretical and empirical analysis. Furthermore, we identify that insufficient side-chain modeling limits geometric representation of NSAAs. To address this, we introduce Progressive Side-chain Perception (PSP) for coarse-to-fine torsion and location prediction, and Interaction-Aware Weighting (IAW) to emphasize pocket-proximal residues. Moreover, NS-Pep generalizes naturally to the peptide folding task with NSAAs, addressing a major limitation of current tools. Experiments show that NS-Pep improves sequence recovery rate and binding affinity by 6.23% and 5.12%, respectively, and outperforms AlphaFold3 by 17.76% in peptide folding success rate.

Flow Autoencoders are Effective Protein Tokenizers

2025-09-30T23:29:39Z

Protein structure tokenizers enable the creation of multimodal models of protein structure, sequence, and function. Current approaches to protein structure tokenization rely on bespoke components that are invariant to spatial symmetries, but that are challenging to optimize and scale. We present Kanzi, a flow-based tokenizer for tokenization and generation of protein structures. Kanzi consists of a diffusion autoencoder trained with a flow matching loss. We show that this approach simplifies several aspects of protein structure tokenizers: frame-based representations can be replaced with global coordinates, complex losses are replaced with a single flow matching loss, and SE(3)-invariant attention operations can be replaced with standard attention. We find that these changes stabilize the training of parameter-efficient models that outperform existing tokenizers on reconstruction metrics at a fraction of the model size and training cost. An autoregressive model trained with Kanzi outperforms similar generative models that operate over tokens, although it does not yet match the performance of state-of-the-art continuous diffusion models. Code is available here: https://github.com/rdilip/kanzi/.

Thin Bridges for Drug Text Alignment: Lightweight Contrastive Learning for Target Specific Drug Retrieval

2025-09-30T20:14:28Z

Multimodal foundation models hold promise for drug discovery and biomedical applications, but most existing approaches rely on heavy pretraining or large scale multimodal corpora. We investigate whether thin contrastive bridges, lightweight projection heads over frozen unimodal encoders can align chemical and textual representations without training a full multimodal model. Using paired mechanisms from ChEMBL, we align ECFP4 molecular fingerprints with biomedical sentence embeddings through dual linear projections trained with a contrastive objective. To better handle drugs sharing the same therapeutic target, we incorporate hard negative weighting and a margin loss. Evaluation under scaffold based splits, which require generalization across disjoint chemical cores, demonstrates that our approach achieves non-trivial cross modal alignment and substantially improves within target discrimination compared to frozen baselines. These results suggest that thin bridges offer a compute efficient alternative to large scale multimodal pretraining, enabling scaffold aware drug text alignment and target specific retrieval in precision medicine.

Commutative algebra neural network reveals genetic origins of diseases

2025-09-30T17:31:17Z

Genetic mutations can disrupt protein structure, stability, and solubility, contributing to a wide range of diseases. Existing predictive models often lack interpretability and fail to integrate physical and chemical interactions critical to molecular mechanisms. Moreover, current approaches treat disease association, stability changes, and solubility alterations as separate tasks, limiting model generalizability. In this study, we introduce a unified framework based on multiscale commutative algebra to capture intrinsic physical and chemical interactions for the first time. Leveraging Persistent Stanley-Reisner Theory, we extract multiscale algebraic invariants to build a Commutative Algebra neural Network (CANet). Integrated with transformer features and auxiliary physical features, we apply CANet to tackle three key domains for the first time: disease-associated mutations, mutation-induced protein stability changes, and solubility changes upon mutations. Across six benchmark tasks, CANet and its gradient boosting tree counterpart, CATree, consistently attain state-of-the-art performance, achieving up to 7.5% improvement in predictive accuracy. Our approach offers multiscale, mechanistic, interpretable,and generalizable models for predicting disease-mutation associations.

MarS-FM: Generative Modeling of Molecular Dynamics via Markov State Models

2025-09-30T15:13:24Z

Molecular Dynamics (MD) is a powerful computational microscope for probing protein functions. However, the need for fine-grained integration and the long timescales of biomolecular events make MD computationally expensive. To address this, several generative models have been proposed to generate surrogate trajectories at lower cost. Yet, these models typically learn a fixed-lag transition density, causing the training signal to be dominated by frequent but uninformative transitions. We introduce a new class of generative models, MSM Emulators, which instead learn to sample transitions across discrete states defined by an underlying Markov State Model (MSM). We instantiate this class with Markov Space Flow Matching (MarS-FM), whose sampling offers more than two orders of magnitude speedup compared to implicit- or explicit-solvent MD simulations. We benchmark Mars-FM ability to reproduce MD statistics through structural observables such as RMSD, radius of gyration, and secondary structure content. Our evaluation spans protein domains (up to 500 residues) with significant chemical and structural diversity, including unfolding events, and enforces strict sequence dissimilarity between training and test sets to assess generalization. Across all metrics, MarS-FM outperforms existing methods, often by a substantial margin.

Marginal Girsanov Reweighting: Stable Variance Reduction via Neural Ratio Estimation

2025-09-30T07:07:25Z

Recovering unbiased properties from biased or perturbed simulations is a central challenge in rare-event sampling. Classical Girsanov Reweighting (GR) offers a principled solution by yielding exact pathwise probability ratios between perturbed and reference processes. However, the variance of GR weights grows rapidly with time, rendering it impractical for long-horizon reweighting. We introduce Marginal Girsanov Reweighting (MGR), which mitigates variance explosion by marginalizing over intermediate paths, producing stable and scalable weights for long-timescale dynamics. Experiments demonstrate that MGR (i) accurately recovers kinetic properties from umbrella-sampling trajectories in molecular dynamics, and (ii) enables efficient Bayesian parameter inference for stochastic differential equations with temporally sparse observations.

TR2-D2: Tree Search Guided Trajectory-Aware Fine-Tuning for Discrete Diffusion

2025-09-29T17:58:45Z

Reinforcement learning with stochastic optimal control offers a promising framework for diffusion fine-tuning, where a pre-trained diffusion model is optimized to generate paths that lead to a reward-tilted distribution. While these approaches enable optimization without access to explicit samples from the optimal distribution, they require training on rollouts under the current fine-tuned model, making them susceptible to reinforcing sub-optimal trajectories that yield poor rewards. To overcome this challenge, we introduce TRee Search Guided TRajectory-Aware Fine-Tuning for Discrete Diffusion (TR2-D2), a novel framework that optimizes reward-guided discrete diffusion trajectories with tree search to construct replay buffers for trajectory-aware fine-tuning. These buffers are generated using Monte Carlo Tree Search (MCTS) and subsequently used to fine-tune a pre-trained discrete diffusion model under a stochastic optimal control objective. We validate our framework on single- and multi-objective fine-tuning of biological sequence diffusion models, highlighting the overall effectiveness of TR2-D2 for reliable reward-guided fine-tuning in discrete sequence generation.

Token-Level Guided Discrete Diffusion for Membrane Protein Design

2025-09-28T23:55:49Z

Reparameterized diffusion models (RDMs) have recently matched autoregressive methods in protein generation, motivating their use for challenging tasks such as designing membrane proteins, which possess interleaved soluble and transmembrane (TM) regions. We introduce the Membrane Diffusion Language Model (MemDLM), a fine-tuned RDM-based protein language model that enables controllable membrane protein sequence design. MemDLM-generated sequences recapitulate the TM residue density and structural features of natural membrane proteins, achieving comparable biological plausibility and outperforming state-of-the-art diffusion baselines in motif scaffolding tasks by producing lower perplexity, higher BLOSUM-62 scores, and improved pLDDT confidence. To enhance controllability, we develop Per-Token Guidance (PET), a novel classifier-guided sampling strategy that selectively solubilizes residues while preserving conserved TM domains, yielding sequences with reduced TM density but intact functional cores. Importantly, MemDLM designs validated in TOXCAT beta-lactamase growth assays demonstrate successful TM insertion, distinguishing high-quality generated sequences from poor ones. Together, our framework establishes the first experimentally-validated diffusion-based model for rational membrane protein generation, integrating de novo design, motif scaffolding, and targeted property optimization.

FusionDTI: Fine-grained Binding Discovery with Token-level Fusion for Drug-Target Interaction

2025-09-28T22:13:13Z

Predicting drug-target interaction (DTI) is critical in the drug discovery process. Despite remarkable advances in recent DTI models through the integration of representations from diverse drug and target encoders, such models often struggle to capture the fine-grained interactions between drugs and protein, i.e. the binding of specific drug atoms (or substructures) and key amino acids of proteins, which is crucial for understanding the binding mechanisms and optimising drug design. To address this issue, this paper introduces a novel model, called FusionDTI, which uses a token-level Fusion module to effectively learn fine-grained information for Drug-Target Interaction. In particular, our FusionDTI model uses the SELFIES representation of drugs to mitigate sequence fragment invalidation and incorporates the structure-aware (SA) vocabulary of target proteins to address the limitation of amino acid sequences in structural information, additionally leveraging pre-trained language models extensively trained on large-scale biomedical datasets as encoders to capture the complex information of drugs and targets. Experiments on three well-known benchmark datasets show that our proposed FusionDTI model achieves the best performance in DTI prediction compared with seven existing state-of-the-art baselines. Furthermore, our case study indicates that FusionDTI could highlight the potential binding sites, enhancing the explainability of the DTI prediction.

PDFBench: A Benchmark for De novo Protein Design from Function

2025-09-28T03:52:13Z

Function-guided protein design is a crucial task with significant applications in drug discovery and enzyme engineering. However, the field lacks a unified and comprehensive evaluation framework. Current models are assessed using inconsistent and limited subsets of metrics, which prevents fair comparison and a clear understanding of the relationships between different evaluation criteria. To address this gap, we introduce PDFBench, the first comprehensive benchmark for function-guided denovo protein design. Our benchmark systematically evaluates eight state-of-the-art models on 16 metrics across two key settings: description-guided design, for which we repurpose the Mol-Instructions dataset, originally lacking quantitative benchmarking, and keyword-guided design, for which we introduce a new test set, SwissTest, created with a strict datetime cutoff to ensure data integrity. By benchmarking across a wide array of metrics and analyzing their correlations, PDFBench enables more reliable model comparisons and provides key insights to guide future research.

ABConformer: Physics-inspired Sliding Attention for Antibody-Antigen Interface Prediction

2025-09-27T11:12:04Z

Accurate prediction of antibody-antigen (Ab-Ag) interfaces is critical for vaccine design, immunodiagnostics, and therapeutic antibody development. However, achieving reliable predictions from sequences alone remains a challenge. In this paper, we present ABCONFORMER, a model based on the Conformer backbone that captures both local and global features of a biosequence. To accurately capture Ab-Ag interactions, we introduced the physics-inspired sliding attention, enabling residue-level contact recovery without relying on three-dimensional structural data. ABConformer can accurately predict paratopes and epitopes given the antibody and antigen sequence, and predict pan-epitopes on the antigen without antibody information. In comparison experiments, ABCONFORMER achieves state-of-the-art performance on a recent SARS-CoV-2 Ab-Ag dataset, and surpasses widely used sequence-based methods for antibody-agnostic epitope prediction. Ablation studies further quantify the contribution of each component, demonstrating that, compared to conventional cross-attention, sliding attention significantly enhances the precision of epitope prediction. To facilitate reproducibility, we will release the code under an open-source license upon acceptance.

Controlled protein synthesis and spatial organisation in microfluidic environments

2025-09-26T12:47:38Z

Performing cell-free expression (CFE) in tailored microfluidic environments is a powerful tool to investigate the organisation of biosystems from molecular to multicellular scales. While cell-free transcription-translation systems simplify and open up cellular biochemistry for manipulation, microfluidics enables miniaturisation and precise control over geometries and reaction conditions. In this review, we highlight the benefits of combining microfluidics with CFE reactions for the study and engineering of molecular functions and the construction of life-like systems from non-living components. By defining spatial organisation at different scales and sustaining non-equilibrium conditions, microfluidic environments play a key role in the quest to boot up the biochemistry of life.

Conditional Latent Space Molecular Scaffold Optimization for Accelerated Molecular Design

2025-09-26T04:21:40Z

The rapid discovery of new chemical compounds is essential for advancing global health and developing treatments. While generative models show promise in creating novel molecules, challenges remain in ensuring the real-world applicability of these molecules and finding such molecules efficiently. To address this challenge, we introduce Conditional Latent Space Molecular Scaffold Optimization (CLaSMO), which integrates a Conditional Variational Autoencoder (CVAE) with Latent Space Bayesian Optimization (LSBO) to strategically modify molecules while preserving similarity to the original input, effectively framing the task as constrained optimization. Our LSBO setting improves the sample-efficiency of the molecular optimization, and our modification approach helps us to obtain molecules with higher chances of real-world applicability. CLaSMO explores substructures of molecules in a sample-efficient manner by performing BO in the latent space of a CVAE conditioned on the atomic environment of the molecule to be optimized. Our extensive evaluations across diverse optimization tasks, including rediscovery, docking score, and multi-property optimization, show that CLaSMO efficiently enhances target properties, delivers remarkable sample-efficiency crucial for resource-limited applications while considering molecular similarity constraints, achieves state of the art performance, and maintains practical synthetic accessibility. We also provide an open-source web application that enables chemical experts to apply CLaSMO in a Human-in-the-Loop setting.

A Hierarchical Adaptive Diffusion Model for Flexible Protein-Protein Docking

2025-09-24T20:19:27Z

Structural prediction of protein-protein interactions is important to understand the molecular basis of cellular interactions, but it still faces major challenges when significant conformational changes are present. We propose a generative framework of hierarchical adaptive diffusion to improve accuracy and efficiency in such cases. It is hierarchical in separating global inter-protein rigid-body motions and local intra-protein flexibility in diffusion processes, and the distinct local and global noise schedules are designed to mimic the induced-fit effect. It is adaptive in conditioning the local flexibility schedule on predicted levels of conformational change, allowing faster flexing for larger anticipated conformational changes. Furthermore, it couples the local and global diffusion processes through a common score and confidence network with sequence, evolution, structure, and dynamics features as inputs, and maintains rotational or translational invariance or equivariance in outputs. It builds on our newly curated DIPS-AF dataset of nearly 39,000 examples for pre-training. Experiments on the independent docking benchmark dataset DB5.5 show that our model outperforms an AlphaFold2-like iterative transformer (GeoDock) and a diffusion model (DiffDock-PP) in both rigid and flexible cases, with larger improvements in more flexible cases. Ablation studies prove the importance of adaptive schedules, dynamics features, and pre-training. Additional analyses and case studies reveal remaining gaps in sampling, scoring, and conformational resolution.

A Foundation Chemical Language Model for Comprehensive Fragment-Based Drug Discovery

2025-09-23T21:23:36Z

We introduce FragAtlas-62M, a specialized foundation model trained on the largest fragment dataset to date. Built on the complete ZINC-22 fragment subset comprising over 62 million molecules, it achieves unprecedented coverage of fragment chemical space. Our GPT-2 based model (42.7M parameters) generates 99.90% chemically valid fragments. Validation across 12 descriptors and three fingerprint methods shows generated fragments closely match the training distribution (all effect sizes < 0.4). The model retains 53.6% of known ZINC fragments while producing 22% novel structures with practical relevance. We release FragAtlas-62M with training code, preprocessed data, documentation, and model weights to accelerate adoption.